Patents Assigned to ABARCEO PHARMA AB
  • NOVEL VDAC1 INHIBITORS
    Publication number: 20230348464
    Abstract: The present invention relates to a compound of general formula I wherein R1-7, Hy, and X are as defined in claim 1. Such compound of formula I binds to VDAC1 and is suitable for use in a method for treating diabetes or pre-diabetes in a subject in need thereof.
    Type: Application
    Filed: December 18, 2020
    Publication date: November 2, 2023
    Applicant: ABARCEO PHARMA AB
    Inventors: William Dalby BROWN, Kristian Tage HANSEN, Sebastian Albert SALEHI